Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | Mínimo Máximo |
||||||
| Minimo del Dia | |||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Invitae Corporation | NVTA | NYSE | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0891 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.0891 |
| Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
|---|---|---|---|
| 0 | 0 | - | 0.081 - 1.67 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | US$ 0.0891 | USD |
Información Financiera Invitae Corporation NVTA
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| US$ 25.53M | - | - | - | -0.82 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Invitae Corporation NVTA
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 06/3/2024 | 07:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06/2/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30/1/2024 | 06:00 | PR Newswire (US) | Invitae Partners with BridgeBio Pharma to Harness Genetic.. |
| 29/1/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 24/1/2024 | 15:34 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 22/1/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/1/2024 | 06:00 | PR Newswire (US) | Invitae Completes Sale of Reproductive Health Assets to.. |
| 18/1/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/12/2023 | 20:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 21/12/2023 | 20:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14/12/2023 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/12/2023 | 15:07 | PR Newswire (US) | Invitae Divests Ciitizen Health Data Platform and Implements.. |
Histórico de Datos NVTA
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.386 | 0.4532 | 0.081 | 0.1780429 | 18,741,976 | -0.2969 | -76.92% |
| 6 Months | 0.60 | 0.7639 | 0.081 | 0.4859813 | 8,468,673 | -0.5109 | -85.15% |
| 1 Year | 1.25 | 1.67 | 0.081 | 0.8407584 | 9,278,358 | -1.16 | -92.87% |
| 3 Years | 36.96 | 38.42 | 0.081 | 5.49 | 8,127,376 | -36.87 | -99.76% |
| 5 Years | 23.18 | 61.59 | 0.081 | 10.78 | 5,970,924 | -23.09 | -99.62% |
